A majority of patients demonstrate late-onset symptoms after age of 65, while approximately 5% of AD patients develop early-onset symptoms before age 65 due to genetic predisposition such as genetic mutations in amyloid precursor protein (APP) and presenilins 1/2 (PSEN1/PSEN2) [2]. The gene discussed is PSEN1; the disease is Alzheimer disease.